Skip to search formSkip to main contentSkip to account menu

Cancer/Testis Antigen 2

Known as: LAGE-1, Autoimmunogenic Cancer/Testis Antigen NY-ESO-2, CT6.2 
Cancer/testis antigen 2 (210 aa, ~21 kDa) is encoded by the human CTAG2 gene. This protein may play a role in tumorigenesis of several tissues.
National Institutes of Health

Related topics

Related topics

4 relations
CTAG2 geneCancer Promoting GenesMetastasis InductionNeoplastic Cell Transformation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
The therapeutic efficacy of LAGE-1 DNA tumor vaccine to the tumor
  • X. Yi
  • 2011
  • Corpus ID: 87571904
pcDNA3.1/LAGE-1 eukaryotic expression vector was constructed and transfected into EMT6 cells;BalB/c mice were divided into 4… 
2004
2004
[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
OBJECTIVE To investigate the possibility of utilizing cancer-testi (CT) antigens as targets for immunotherapy of non-small cell… 
2003
2003
Targets for Immunotherapy in Epithelial Ovarian Cancer NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential
Cancer-testis (CT) antigens are expressed in a variety of cancers, but not in normal adult tissues, except for germ cells of the… 
Review
2002
Review
2002
Towards Defining Specific Antigens for Cutaneous Lymphomas
Cutaneous lymphomas (CLs) are a heterogeneous group of malignancies of T-cell (cutaneous T-cell lymphoma, CTCL) or B-cell… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)